| Okahara & Olsen M.d.,inc. | |
|
670 Ponahawai St Suite 208 Hilo HI 96720-2660 | |
| (808) 935-2112 | |
| (808) 935-2110 |
| Full Name | Okahara & Olsen M.d.,inc. |
|---|---|
| Speciality | Family Medicine |
| Location | 670 Ponahawai St, Hilo, Hawaii |
| Authorized Official Name and Position | Kara Mitsuyo Okahara (VICE PRESIDENT) |
| Authorized Official Contact | 8089352112 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Okahara & Olsen M.d.,inc. 670 Ponahawai St Suite 208 Hilo HI 96720-2660 Ph: (808) 935-2112 | Okahara & Olsen M.d.,inc. 670 Ponahawai St Suite 208 Hilo HI 96720-2660 Ph: (808) 935-2112 |
| NPI Number | 1942409040 |
|---|---|
| Provider Enumeration Date | 07/17/2007 |
| Last Update Date | 07/17/2007 |
| Medicare PECOS PAC ID | 3577451798 |
|---|---|
| Medicare Enrollment ID | O20100721000762 |
News Archive
Scientists at Duke Health are part of a team that has discovered a type of cell surrounding blood vessels can also serve as a starting point for sarcoma, a form of cancer that occurs in bones and connective tissues.
A Phase 3 clinical trial demonstrates that tofacitinib improves disease activity and inhibits progression of joint damage in rheumatoid arthritis (RA) patients who did not respond to methotrexate (MTX).
The community-associated strain of the deadly superbug MRSA-an infection-causing bacteria resistant to most common antibiotics-poses a far greater health threat than previously known and is making its way into hospitals, according to a study in the December issue of Emerging Infectious Diseases.
A new study has been published on the medRxiv* preprint server, which focuses on the development of a dual-antigen COVID-19' T cell' vaccine. This vaccine is developed based on the expression of both S protein and nucleocapsid (N) protein of SARS-CoV-2, using a next-generation human adenovirus serotype 5 (Ad5) platform.
Ingenza has teamed up with clinical scientists at Imperial College London to trial an improved diagnostic assay for confirming nasogastric (NG) tube placement. Professor George Hanna, Director of the National Institute for Health Research Diagnostic Evidence Co-operative London at Imperial College Healthcare NHS Trust, which specialises in In Vitro Diagnostics, explained: "Correct placement of NG tubes is vital, as accidental insertion of the tube into the lung instead of the gut can have serious consequences.
› Verified 3 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1942409040 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 10628 (Hawaii) | Primary |
| Provider Name | Douglas Craig Olsen |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1235273616 PECOS PAC ID: 4880582907 Enrollment ID: I20110228000860 |
News Archive
Scientists at Duke Health are part of a team that has discovered a type of cell surrounding blood vessels can also serve as a starting point for sarcoma, a form of cancer that occurs in bones and connective tissues.
A Phase 3 clinical trial demonstrates that tofacitinib improves disease activity and inhibits progression of joint damage in rheumatoid arthritis (RA) patients who did not respond to methotrexate (MTX).
The community-associated strain of the deadly superbug MRSA-an infection-causing bacteria resistant to most common antibiotics-poses a far greater health threat than previously known and is making its way into hospitals, according to a study in the December issue of Emerging Infectious Diseases.
A new study has been published on the medRxiv* preprint server, which focuses on the development of a dual-antigen COVID-19' T cell' vaccine. This vaccine is developed based on the expression of both S protein and nucleocapsid (N) protein of SARS-CoV-2, using a next-generation human adenovirus serotype 5 (Ad5) platform.
Ingenza has teamed up with clinical scientists at Imperial College London to trial an improved diagnostic assay for confirming nasogastric (NG) tube placement. Professor George Hanna, Director of the National Institute for Health Research Diagnostic Evidence Co-operative London at Imperial College Healthcare NHS Trust, which specialises in In Vitro Diagnostics, explained: "Correct placement of NG tubes is vital, as accidental insertion of the tube into the lung instead of the gut can have serious consequences.
› Verified 3 days ago
| Provider Name | Kara Mitsuyo Okahara |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1417091893 PECOS PAC ID: 1355239575 Enrollment ID: I20110301000513 |
News Archive
Scientists at Duke Health are part of a team that has discovered a type of cell surrounding blood vessels can also serve as a starting point for sarcoma, a form of cancer that occurs in bones and connective tissues.
A Phase 3 clinical trial demonstrates that tofacitinib improves disease activity and inhibits progression of joint damage in rheumatoid arthritis (RA) patients who did not respond to methotrexate (MTX).
The community-associated strain of the deadly superbug MRSA-an infection-causing bacteria resistant to most common antibiotics-poses a far greater health threat than previously known and is making its way into hospitals, according to a study in the December issue of Emerging Infectious Diseases.
A new study has been published on the medRxiv* preprint server, which focuses on the development of a dual-antigen COVID-19' T cell' vaccine. This vaccine is developed based on the expression of both S protein and nucleocapsid (N) protein of SARS-CoV-2, using a next-generation human adenovirus serotype 5 (Ad5) platform.
Ingenza has teamed up with clinical scientists at Imperial College London to trial an improved diagnostic assay for confirming nasogastric (NG) tube placement. Professor George Hanna, Director of the National Institute for Health Research Diagnostic Evidence Co-operative London at Imperial College Healthcare NHS Trust, which specialises in In Vitro Diagnostics, explained: "Correct placement of NG tubes is vital, as accidental insertion of the tube into the lung instead of the gut can have serious consequences.
› Verified 3 days ago
News Archive
Scientists at Duke Health are part of a team that has discovered a type of cell surrounding blood vessels can also serve as a starting point for sarcoma, a form of cancer that occurs in bones and connective tissues.
A Phase 3 clinical trial demonstrates that tofacitinib improves disease activity and inhibits progression of joint damage in rheumatoid arthritis (RA) patients who did not respond to methotrexate (MTX).
The community-associated strain of the deadly superbug MRSA-an infection-causing bacteria resistant to most common antibiotics-poses a far greater health threat than previously known and is making its way into hospitals, according to a study in the December issue of Emerging Infectious Diseases.
A new study has been published on the medRxiv* preprint server, which focuses on the development of a dual-antigen COVID-19' T cell' vaccine. This vaccine is developed based on the expression of both S protein and nucleocapsid (N) protein of SARS-CoV-2, using a next-generation human adenovirus serotype 5 (Ad5) platform.
Ingenza has teamed up with clinical scientists at Imperial College London to trial an improved diagnostic assay for confirming nasogastric (NG) tube placement. Professor George Hanna, Director of the National Institute for Health Research Diagnostic Evidence Co-operative London at Imperial College Healthcare NHS Trust, which specialises in In Vitro Diagnostics, explained: "Correct placement of NG tubes is vital, as accidental insertion of the tube into the lung instead of the gut can have serious consequences.
› Verified 3 days ago
Rainbow Healthcare Services Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 43 E Lanikaula St, Hilo, HI 96720 Phone: 808-238-4922 | |
Carlos R. Abeyta Md, Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 82 Puuhonu Pl, Suite 206, Hilo, HI 96720 Phone: 808-969-9888 Fax: 808-969-9881 | |
Joyful Living, Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1248 Kinoole St, Suite 101, Hilo, HI 96720 Phone: 808-935-8398 | |
Administration Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 450 Kilauea Ave Ste 105, Hilo, HI 96720 Phone: 808-961-4071 Fax: 808-961-5678 | |
Craig Y. Shikuma, M.d., Inc. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 82 Puuhonu Pl, Suite 207, Hilo, HI 96720 Phone: 808-935-5522 Fax: 808-961-5058 | |
J Nohea Kaawaloa Md Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 670 Ponahawai St, Suite 220, Hilo, HI 96720 Phone: 808-933-1120 Fax: 808-933-1125 | |
Big Island Family Medicine Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 670 Ponahawai St Ste 207, Hilo, HI 96720 Phone: 808-365-5988 Fax: 808-365-5989 |